Atlas FDA

AFX2 Endovascular AAA System

FDA premarket approval P040002/S075 · decided 2024-09-27

Approval details

PMA number
P040002
Supplement
S075
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
AFX2 Endovascular AAA System
Generic name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Applicant
Endologix, LLC
Date received
2024-08-30
Decision date
2024-09-27
Days to decision
28 days
Decision code
OK30
Product code
MIH
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
implementation of a revised ethylene oxide sterilization cycle at one of the sterilization sites and use of a new biological indicator

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.